11 results
diabetes management dosing inhibitors table acromegaly agonists antidiabetic comparison decisionaid development diabetic differential dm1 dpp4 druginduced eudka euglycemic glp1 hyperkalemia
Profiles of Antidiabetic Medications - AACE 2018 #Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #Antidiabetic #Medications ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology ... #Pharmacology #
Mechanism of Action for Common Diabetes Medications • SGLT2i (Dapagliflozin) • TZD (Pioglitazone) • Biguanides (Metformin)
Common Diabetes Medications ... #Diabetes #Medications ... #pharmacology # ... pathophysiology ... #endocrinology
Stages in the Development of Diabetes Type 1 #Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
#Type1 #TypeI #DM1 ... #Development #Pathophysiology ... #Timeline #Diagnosis ... #Endocrinology
Stress Dose Steroids - Indications and Dosing SUPPRESSED HPA AXIS: prednisone >20mg/day x 3 weeks or more
Dose Steroids - Indications ... StressDose #Steroids #Indications ... #Dosing #Endocrinology ... #Diagnosis #Management ... #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology # ... comparison #table #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2 ... #Diabetes #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
different than other medications ... very tolerable medication ... Renal #Dosing #Pharmacology ... Management #Diabetes #DM2 ... #Endocrinology
Mechanisms of Drug-Induced Hyperkalemia • Direct renin inhibitor (Aliskiren) • Renin release inhibition (NSAIDs, Beta-Blockers)
#differential #diagnosis ... #pathophysiology ... #pharmacology # ... potassium #medications
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
commonly used medications ... mistaken these medications ... GLP1 #Agonists #Pharmacology ... Dosing #Diabetes #DM2 ... #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA) SGLT2 Inhibitors Increasing Indications Significant Adverse Drug Effects Definition of EuDKA • Metabolic acidosis with pH
Inhibitors Increasing Indications ... level < 200 mg/dL Pathophysiology ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
No results found for "NCPE pathophysiology pharmacology medications endocrinology dm2 diagnosis"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #NCPE #pathophysiology #pharmacology #medications #endocrinology #dm2 #diagnosis